Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02411188
Other study ID # UManitoba
Secondary ID
Status Withdrawn
Phase N/A
First received March 30, 2015
Last updated October 31, 2016
Start date February 2016
Est. completion date October 2018

Study information

Verified date November 2015
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The goal of the proposed project is to determine if providing an intervention for women who decline the invitation to participate in standard cardiac rehabilitation programs (CRPs) will ultimately result in an increase their participation in CRPs.This study will evaluate outcomes of patients randomized to the FHHS STEP Program versus by non-STEP Program participants. The overall goal is to provide an alternate, introductory program that will engage, educate, and empower women following a cardiac event. Providing these women with the necessary personal resources will encourage and enable these women to take the step towards a cardiac rehabilitation program, which, in turn will ideally lead to a life-long commitment to heart health.


Description:

Cardiac rehabilitation programs (CRPs) have been shown to improve outcomes following a cardiac event. Referrals to the CRP are a standard part of the community-based continuing care process within the Winnipeg region, to include automatic referrals for hospitalized patients, based on specific criteria, physician referrals and self-referrals. However, fewer women than men are referred to and participate in CRPs in Winnipeg.

The investigators' study is unique in that the investigators plan to capture those women who may not be ready to change or participate in a traditional CRP. While women who are in the pre-contemplative or contemplative stages of change may not be ready to participate in a standard CRP, they may be willing to explore a complementary opportunity: the FHHS STEP Program. The overall goal of this project is to provide a collaborative team environment that will engage women; educate, and empower women; and provide women with the necessary personal resources to enable them to take the step towards a cardiac rehabilitation program and a life-long commitment to heart health. The investigators' 2-group randomized clinical trial will compare physiological and psychosocial outcomes among women completing a 12-week gender specific introduction to cardiac rehabilitation with non-program attenders.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 2018
Est. primary completion date March 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Discharged from a Winnipeg Regional Health Authority (WRHA) facility;

- Diagnosis of stable ischemic heart disease or acute coronary syndrome who have undergone revascularization via coronary artery bypass graft (CABG) surgery or elective percutaneous coronary intervention (PCI);

- Diagnosis of valvular heart disease who have undergone valve surgery;

- Diagnosis of stable ischemic or non-ischemic heart failure;

- Able to read, write, and speak English;

- Referred to and declined participation in a CRP in Winnipeg;

- Willing and able to attend the STEP Program at the Victoria General Hospital.

Exclusion Criteria:

- Patients who have unstable or recent unstable cardiac syndrome, as defined by:

- Severe heart failure (New York Heart Association Class IV) or angina (Canadian Cardiovascular Society Class IV) symptoms

- Non-re-vascularized > triple vessel disease

- Non-repaired severe valvular heart disease (aortic or mitral area < 1.0cm2 or mean gradient > 40 mmhg or > 10mmHg [millimetres of mercury] respectively)

- Severe systolic heart failure (LVEF [left ventricular ejection fraction] < 30%)

- High risk stress test

- Exercise induced ventricular arrhythmias or recent (within the past 6 months) hospitalization for ventricular arrhythmias

- Unstable arrhythmias (i.e., bradycardia; tachyarrhythmias)

- Previous attendance in a CRP

- Physical limitations that would preclude ability to walk

- Cognitive impairment/deficits that would preclude participation in the STEP Project

- Automatic internal cardiac defibrillator in situ

- On waitlist for cardiac procedure (e.g., cardiac surgery; PCI)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
The STEP Program
Intervention: The 12-week STEP Program will include: initial individual consult/goal setting; weekly 90 minute information/interactive sessions; individualized patient centred care; journaling

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
University of Manitoba Reh-Fit Fitness Centre, Victoria General Hospital Foundation, Wellness Institute-Seven Oaks General Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiac Rehabilitation Program Enrolment 3 yes/no questions: have you contacted a CRP; have you joined a CRP; do you plan to contact a CRP. if not, why not 12 months No
Secondary Short-Form-36 36 items re 8 dimensions: physical functioning (10 items), role limitations - physical (4 items), bodily pain (2 items), social functioning (2 items), general mental health (5 items), role limitations - emotional (3 items), vitality (4 items), general health perceptions, 5 items); coded to 0-100 score, with higher values representing more favourable states baseline, 3, 6 and 12 months No
Secondary Brief Symptom Inventory 53 items; 5-point Likert scale (1-5); operationalizes concepts of anxiety, depression and hostility; 9 symptom domains, with higher scores indicating greater levels of distress. baseline, 3, 6 and 12 months No
Secondary General Self-Efficacy Scale 10 items; scoring based on 4-point Likert scale (1-4), with higher scores reflecting higher perceived self-efficacy baseline, 3, 6, 12 months No
Secondary Multidimensional Self-Efficacy for Exercise Scale 9 items; 11-point Likert scale (0-10), with higher scores reflecting higher task efficacy (3 items), coping efficacy (3 items) and scheduling efficacy (3 items baseline, 3, 6 and 12 months No
Secondary Enhancing Recovery in Coronary Heart Disease Social Support Instrument 7 item scale is scored by totalling the six 5-point Likert scale items and a 7th item, which is scored 4 for 'yes' and 2 for 'no'. The scale captures structural, emotional and instrumental support baseline, 3, 6 and 12 months No
Secondary Stages of Change Questionnaire 12 5-point-Likert scale (1-5) questions; Stages of readiness to change for each of the listed behaviors include 5 response items representing each of the stages of change (i.e., precontemplation, contemplation, preparation, action, and maintenance). baseline, 3, 6 and 12 months No
Secondary Health Resource Utilization Questionnaire 4-items: self-reported number of contacts/visits with primary care provider, cardiologist, emergency department/Walk-in Clinic visits and hospital admissions. 3, 6 and 12 months No
Secondary International Physical Activity Questionnaire 9-item, subjective 7 day recall of physical activity patterns baseline, 3, 6 and 12 months No
Secondary Client Satisfaction Questionnaire intervention group only; 8 items; 4-point Likert scale; assesses general satisfaction with the health care services received; higher scores reflect higher satisfaction 3 months No
Secondary 6-Minute Walk Test total distanced walked in 6 minutes baseline, 3, 6 and 12 months No
Secondary Accelerometry accelerometers monitor/measure physical activity/sedentary behaviours for a specified period of time (7 days). baseline, 3, 6 and 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)